Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Hemasphere
|
May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 5, 2015
Myelodysplastic syndromes, version 2.2015
Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 2, 2017
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Peter L Greenberg, Richard M Stone, Aref Al-Kali, et al.
Blood
|
April 30, 2020
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Luca Malcovati, Kristen Stevenson, Elli Papaemmanuil, et al.
Nature Communications
|
April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Blood
|
September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Blood Reviews
|
March 18, 2023
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Leukemia
|
January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Leukemia
|
October 20, 2022
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Hemasphere
|
May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 5, 2015
Myelodysplastic syndromes, version 2.2015
Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 2, 2017
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Peter L Greenberg, Richard M Stone, Aref Al-Kali, et al.
Blood
|
April 30, 2020
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Luca Malcovati, Kristen Stevenson, Elli Papaemmanuil, et al.
Nature Communications
|
April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Blood
|
September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Blood Reviews
|
March 18, 2023
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Leukemia
|
January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Leukemia
|
October 20, 2022
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, et al.
Page
of 11